DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	IGHV3-11; IGHV4-39; IGHV3-74; IGHV1-69; IGLL5; IGHG2; IGHV3-30; IGHV1-2; IGHV4-4; IGHV3-43; IGHV4-28; TRDC; IGLC6; IGHV1-46; IGHV3-64; IGHV3-66; IGHV3-72; TRBC2; IGHA2; IGHV1-3; IGHV1-18; IGHG4; IGHV3-15; IGHV3-49; IGHV1-69-2; IGHV3-20; IGHV3-21; IGLC7; IGLC3; IGHV3-23; IGHV3-13; IGHV2-70; IGHV3-53; IGHG3; IGHV3-7; IGHV1-58; IGHV4-61; IGHV2-5; IGHD; IGHV2-26; TRBC1; IGHV5-51; IGHV3-73; IGLC2; IGKC; IGHV6-1; IGHV4-31; IGHV3-48; IGHV1-24; IGHV4-59; IGHV4-34; IGHV3-33;	GO:0006910~phagocytosis, recognition	52	99	52.5252525252525	0	0	0	0	0	0	0
up	IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; FCN1; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; C1QA; C1QB; C1QC; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; IGLC6; IGLC2; IGLC3; IGHV1-2; IGLV3-21;	GO:0006956~complement activation	59	92	64.1304347826087	0	0	0	0	0	0	0
up	IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; C1QA; C1QB; C1QC; C4BPA; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; IGLC6; IGLC2; IGLC3; IGHV1-2; IGLV3-21; IGHV1-18; TRDC; IGHV4-4; IGHV3-21; IGHV5-51; IGHV3-20; IGHD; IGHV1-24; IGHV1-69-2; IGHV3-49; IGHV4-61; IGHV4-31; TRBC2; IGLL5; IGHV4-28; IGHV2-26; IGHV3-15; TRBC1; IGHV6-1; IGHV3-74; IGHV3-64; IGHV1-3; IGHV3-66; IGHV3-72; IGHA2; IGHV1-58; IGHV3-43; IGHV3-73;	GO:0006958~complement activation, classical pathway	87	161	54.0372670807453	0	0	0	0	0	0	0
up	TNFRSF13B; LILRA1; IFNG; IL2RA; CD3D; CD3G; CXCR1; KLRC1; CXCR3; CCR5; ADGRE1; LILRB2; ADGRE3; CLEC1B; CLEC4A; TRBV24-1; TRBV6-4; TRBV19; TRBV6-6; TRBV5-1; CD80; TRBV6-1; TRBV27; TRBV5-5; TRBV3-1; TRBV2; TRBV13; TRBV28; TRBV6-2; TRBV11-1; TRBV25-1; TRBV7-2; TRBV4-1; TRBV11-3; TRBV7-6; TRBV29-1; TRBV10-1; TRBV7-7; TRBV14; TRBV15; TRBV5-7; TRBV30; TRBV10-2; TRBV6-7; TRBV4-2; TRBV20-1; TRBV7-4; TRBV12-5; TRBV6-5; TRBV12-4; TRBV5-6; TRBV16; TRBV23-1; TRBV5-4; TRBV9; TRBV12-3; TRBV18; TRBV7-9; TRBV11-2; TRBV10-3;	GO:0007166~cell surface receptor signaling pathway	60	268	22.3880597014925	0	0	0	0	0	0	0
up	IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; CD3G; IGLC6; IGLC2; IGLC3; FCGR2A; IGHV1-2; FCGR2B; NCKAP1L; IGLV3-21;	GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis	59	135	43.7037037037037	0	0	0	0	0	0	0
up	HP; S100A8; S100A9; IL10; S100A12; IRF8; CEBPE; TLR9; STAB1; SLAMF8; IGHV3-48; IGHV6-1; IGHG2; IGLC3; IGHG3; IGHV1-46; IGHV3-53; IGHV3-13; IGLC6; IGHV1-24; TRBC1; IGHV3-73; IGHV1-2; TRBC2; IGHV3-30; IGHA2; IGLC2; IGHV3-72; IGLL5; IGHV2-5; IGHD; IGHV3-49; IGHV3-74; IGHV1-18; IGHV2-70; IGHV3-7; IGHV1-58; IGHV4-34; IGHV3-15; IGHV5-51; IGHV3-66; IGHV3-64; IGHV3-23; IGHV1-69; IGHV1-69-2; IGHV4-31; IGLC7; TRDC; IGHV3-20; IGHV4-61; IGHV3-43; IGKC; IGHV4-39; IGHV4-28; IGHV2-26; IGHV4-4; IGHV3-21; IGHV3-11; IGHV4-59; IGHV1-3; IGHV3-33; IGHG4;	GO:0042742~defense response to bacterium	62	216	28.7037037037037	0	0	0	0	0	0	0
up	IGKV2D-30; TRAV19; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; CD300LB; NCR3; TYROBP; LILRA1; NCR1; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; TRBV12-3; TRAV8-4; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; TRBC1; IGLV7-43; CD3D; IGKV1-16; IGKV1D-39; IGKV3-11; TRBV7-9; TRAV29DV5; CD1A; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; CD3G; IGLC6; IGLC2; IGLC3; CD8B; CD19; IGHV1-2; KLRC1; CD1B; CD1C; CD40LG; FCGR2B; ICAM3; KIR2DL1; KIR2DL3; KIR3DL1; KIR3DL2; IGLV3-21; CD300E; TREML2; LAIR2; CLEC4G; TREML4; CD300LD; LILRB2; LILRB1; CD300LF; KIR2DL4; CD300A; SIGLEC7; BTNL8; BTNL3; BTN1A1;	GO:0050776~regulation of immune response	93	216	43.0555555555556	0	0	0	0	0	0	0
up	TLR9; IGHV2-26; IGHV3-53; IGHG3; IGHV3-49; IGHV1-69-2; IGHG4; IGLC7; IGLC3; IGHV3-15; IGHV4-39; IGHV3-64; IGHV4-28; IGHV2-70; IGHV3-21; IGHD; IGHV4-59; IGHV1-69; IGHV4-4; IGHV3-73; IGHV3-23; IGHV3-13; IGHV1-2; TRBC1; IGHV1-18; IGLL5; IGHV1-24; IGHV3-72; IGHV3-74; IGHV3-48; IGHV3-11; TRBC2; IGHG2; IGHV3-33; IGLC2; IGHV3-20; IGHV1-46; IGLC6; IGHV4-31; IGHV5-51; IGHV4-61; IGHV1-3; IGHV6-1; IGHV4-34; IGHV3-66; IGHV1-58; IGHV3-7; IGHA2; TRDC; IGKC; IGHV3-30; IGHV3-43; IGHV2-5;	GO:0050871~positive regulation of B cell activation	53	98	54.0816326530612	0	0	0	0	0	0	0
up	IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; JCHAIN; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHA2; GYPA; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; GYPB; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; CD48; IGLC6; IGLC2; IGLC3; IGHV1-2; CEACAM8; CEACAM3; IGLV3-21; FOXJ1; SIRPG; CD84;	GO:0050900~leukocyte migration	62	193	32.1243523316062	0	0	0	0	0	0	0
down	FGF10; TCF21; PDGFRA; FOXF1; SIX2;	GO:0048557~embryonic digestive tract morphogenesis	5	18	27.7777777777778	0.00011115640207082	0.00553336569508553	0.271443933856948	0.276668284754277	0.246656056195155	0.271221621052806	0.0464639641119874
down	BMP5; TBX2; SGCG; SGCZ; SGCD;	GO:0048738~cardiac muscle tissue development	5	18	27.7777777777778	0.00011115640207082	0.00553336569508553	0.271443933856948	0.276668284754277	0.246656056195155	0.271221621052806	0.0464639641119874
down	UCHL1; LOX; COMP; FLNC; WFIKKN2;	GO:0048747~muscle fiber development	5	18	27.7777777777778	0.00011115640207082	0.00553336569508553	0.271443933856948	0.276668284754277	0.246656056195155	0.271221621052806	0.0464639641119874
down	CHRM2; ADCY2; GNA14; ADRA2C; DRD2; ADRB3; ADRA1B; ADRA1A;	GO:0007188~adenylate cyclase-modulating G protein-coupled receptor signaling pathway	8	62	12.9032258064516	0.00012976182031732	0.00633288570136882	0.316489079753944	0.32297717076981	0.273947548106858	0.316489079753944	0.0531775758495518
down	MGP; COMP; TWIST1; DDR2; OMD;	GO:0030500~regulation of bone mineralization	5	19	26.3157894736842	0.00013792505749421	0.00654932639554138	0.336261290170896	0.343295468103101	0.285107552566851	0.336261290170896	0.0549950397947488
down	FGF10; AGT; LIF; BGN; FOXC2; RSPO3;	GO:0001974~blood vessel remodeling	6	32	18.75	0.00014970748587539	0.0068184838663172	0.364687435592461	0.372621932343857	0.300725522363747	0.364687435592461	0.0572551692985169
down	TRABD2B; NFATC4; SFRP4; NOTUM; DACT3; BARX1; NKD2;	GO:0030178~negative regulation of Wnt signaling pathway	7	47	14.8936170212766	0.00015340903837435	0.0068184838663172	0.373551008441548	0.381835096513763	0.30559080444171	0.373397599403174	0.0572551692985169
down	VEGFD; IGF2; FGF1; FGF2; FGF5; FGF7; PROK1;	GO:0051781~positive regulation of cell division	7	47	14.8936170212766	0.00015340903837435	0.0068184838663172	0.373551008441548	0.381835096513763	0.30559080444171	0.373397599403174	0.0572551692985169
down	BMP5; GDF6; INHBE; GDF5; INHA; LEFTY1; LEFTY2;	GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation	7	48	14.5833333333333	0.00017253946444362	0.00753422328070482	0.419788516991332	0.429450727000175	0.330866700936942	0.419788516991332	0.063265270979159
up	HBZ; HBD; HBG1; HBG2; HBA1; HBM;	GO:0015671~oxygen transport	6	14	42.8571428571429	0.00017378383576838	0.0122413333915248	0.301862522729679	0.30603333478812	0.301514955058143	0.301862522729679	0.0985566482330102
down	FGF10; HOXC11; FGF1; GDNF;	GO:0001759~organ induction	4	10	40	0.00017927224940317	0.00769325222007754	0.435990110548516	0.446208628764497	0.338286734623787	0.435990110548516	0.0646006453857962
down	ADRA1A; ADRA2C; ADRA1B; DRD2; ADRB3;	GO:0071880~adenylate cyclase-activating adrenergic receptor signaling pathway	5	21	23.8095238095238	0.00020597863112015	0.00867231680637879	0.500734052253089	0.512680812858058	0.365370514326019	0.500734052253089	0.0728219024484953
up	LILRA5; IFNG; ORM1; LPL; ORM2; MMP8; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	7	22	31.8181818181818	0.00022439652211092	0.0151985490552823	0.389552362384567	0.39516227543734	0.388654776296123	0.389552362384567	0.122365595722659
down	GRIA1; GRM1; FGF14; KCND2; GABRA2; GABRG3;	GO:0060078~regulation of postsynaptic membrane potential	6	35	17.1428571428571	0.00023082493388237	0.00941841410546296	0.560673764400298	0.574523260433241	0.39009413826122	0.560673764400298	0.0790869208909754
down	COL1A1; COL3A1; COL5A2; COL1A2; MMP2; COL6A1; PDGFRA;	GO:0071230~cellular response to amino acid stimulus	7	51	13.7254901960784	0.00024177318160556	0.00970602337122984	0.587025284938311	0.60177344901625	0.400829405852195	0.587025284938311	0.081501991092234
down	GLI2; SCX; OSR2; OSR1; SIX2; CYTL1;	GO:0002062~chondrocyte differentiation	6	37	16.2162162162162	0.0003017457878971	0.0117350822824357	0.732337027226264	0.751045266075884	0.450583686980654	0.732035281438367	0.0985401059804493
down	AGR2; COL8A1; FOXF1; EGFLAM; CCDC80; EMILIN1;	GO:0010811~positive regulation of cell-substrate adhesion	6	37	16.2162162162162	0.0003017457878971	0.0117350822824357	0.732337027226264	0.751045266075884	0.450583686980654	0.732035281438367	0.0985401059804493
down	LUM; PRELP; FMOD; OMD;	GO:0042340~keratan sulfate catabolic process	4	12	33.3333333333333	0.0003149487703572	0.012060115221832	0.76375076811622	0.783907489419081	0.458880358410446	0.76375076811622	0.101269424746555
down	HAND2; TWIST1; PITX2;	GO:0003253~cardiac neural crest cell migration involved in outflow tract morphogenesis	3	4	75	0.00032537674675925	0.0120875033236386	0.788713234144431	0.809862722683783	0.465288747865733	0.788387857397672	0.101499404084549
down	PALM; DRD2; RGS4;	GO:0060160~negative regulation of dopamine receptor signaling pathway	3	4	75	0.00032537674675925	0.0120875033236386	0.788713234144431	0.809862722683783	0.465288747865733	0.788387857397672	0.101499404084549
down	GREM1; DRD2; NTF3; ANGPT1; SFRP4;	GO:0002092~positive regulation of receptor internalization	5	24	20.8333333333333	0.00035252091885784	0.0129033024564291	0.853805665473703	0.877424567037179	0.482248616997533	0.853805665473703	0.108349712507547
down	CYP26A1; TCF21; AGT; DCN; GLI2; ITGA8; RGN; SIX2; SALL1;	GO:0001822~kidney development	9	94	9.57446808510638	0.00039398330372963	0.01421194844903	0.953833578329456	0.980624442983072	0.501840804441108	0.953833578329456	0.11933848205327
down	ACTC1; SGCD; SGCG; SGCZ;	GO:0060047~heart contraction	4	13	30.7692307692308	0.00040485425167491	0.0143954604631266	0.97974728905329	1	0.506338252930955	0.97974728905329	0.120879442131993
up	CD1A; CD1C; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	4	5	80	0.00041058055606546	0.0267789762678253	0.712357264773582	0.723032359231284	0.660810926168871	0.712357264773582	0.2156011979786
down	FGF2; WNT2; TBX2; ZFPM2; TBX5;	GO:0060045~positive regulation of cardiac muscle cell proliferation	5	25	20	0.00041556890807603	0.0145683241155106	1	1	0.510734188025448	0.999492318039222	0.122330987354781
down	FGF10; GLI2; PDGFRA; HAND2; DLX2; LHX8; AMTN;	GO:0042475~odontogenesis of dentin-containing tooth	7	57	12.280701754386	0.00044685031970304	0.0152357595306968	1	1	0.523708574691963	0.999492318039222	0.127935477801856
down	FGF10; IGF1; FGF7; BMP5; TWIST1; OSR2; OSR1;	GO:0050679~positive regulation of epithelial cell proliferation	7	57	12.280701754386	0.00044685031970304	0.0152357595306968	1	1	0.523708574691963	0.999492318039222	0.127935477801856
down	PITX3; PENK; DRD2; TACR3; RGS4;	GO:0043278~response to morphine	5	26	19.2307692307692	0.00048675751610161	0.0159470655096812	1	1	0.540300842872787	0.999492318039222	0.133908351691164
down	GABRR3; FXYD1; GABRA2; CLCNKB; ANO4; SLC26A9; SLC26A10; CLIC6; GABRG3;	GO:1902476~chloride transmembrane transport	9	97	9.27835051546392	0.00048693329800553	0.0159470655096812	1	1	0.540415604425593	0.999492318039222	0.133908351691164
down	AGT; DRD2; NPPB; EDNRB;	GO:0035815~positive regulation of renal sodium excretion	4	14	28.5714285714286	0.00051168425470238	0.016139503704825	1	1	0.550572258059764	0.999492318039222	0.13552426538378
down	FGF10; VEGFD; NTF3; CXCL12;	GO:0050930~induction of positive chemotaxis	4	14	28.5714285714286	0.00051168425470238	0.016139503704825	1	1	0.550572258059764	0.999492318039222	0.13552426538378
down	APOE; MIF; EDNRB;	GO:0032269~negative regulation of cellular protein metabolic process	3	5	60	0.00051226227106515	0.016139503704825	1	1	0.550808353847633	0.999492318039222	0.13552426538378
down	TCF21; FGF2; HOXD11; GDNF; ADAMTS16; SALL1;	GO:0001658~branching involved in ureteric bud morphogenesis	6	42	14.2857142857143	0.00055447936423869	0.0172512392198763	1	1	0.568341348344659	0.999492318039222	0.144859567245221
down	FGF10; GLI2; NR0B1; ISL1; SALL1;	GO:0021983~pituitary gland development	5	27	18.5185185185185	0.00056674087369768	0.0174150374646114	1	1	0.573541764182052	0.999492318039222	0.146234989760985
down	CTSV; NGF; NTF4; NTF3;	GO:0021675~nerve development	4	15	26.6666666666667	0.00063713132333576	0.0186567042797966	1	1	0.600818180384558	0.999492318039222	0.156661331614922
down	GIP; SCT; SCTR; GPR62;	GO:0043950~positive regulation of cAMP-mediated signaling	4	15	26.6666666666667	0.00063713132333576	0.0186567042797966	1	1	0.600818180384558	0.999492318039222	0.156661331614922
down	SLIT3; ELN; TWIST1; ROBO2; EMILIN1;	GO:0003180~aortic valve morphogenesis	5	28	17.8571428571429	0.00065619134334704	0.0189913982975674	1	1	0.608289375282711	0.999492318039222	0.159471774966608
up	TRPM2; GATA1; FLT3; LILRB1; BATF3;	GO:0097028~dendritic cell differentiation	5	12	41.6666666666667	0.00068409605405972	0.0430247553999705	1	1	0.909163655845373	0.9999999954262	0.346398186181416
down	FGF10; AGT; PENK; COL1A1; NR2F2; TACR3; PTGFR; WFDC1; GGT5;	GO:0032355~response to estradiol	9	103	8.7378640776699	0.00072699967737488	0.0203314853593942	1	1	0.636124717703024	0.999492318039222	0.170724556831895
down	FGF18; COL1A1; MMP2;	GO:0001957~intramembranous ossification	3	6	50	0.00075609657357211	0.0204556996915326	1	1	0.647218666977733	0.999492318039222	0.171767591142062
down	DCN; BGN; EGFLAM;	GO:0019800~peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan	3	6	50	0.00075609657357211	0.0204556996915326	1	1	0.647218666977733	0.999492318039222	0.171767591142062
down	TCF21; LIF; FOXF1;	GO:0060426~lung vasculature development	3	6	50	0.00075609657357211	0.0204556996915326	1	1	0.647218666977733	0.999492318039222	0.171767591142062
up	S100A8; S100A9; CTSG; DEFA4; DEFA3; S100A12; CLEC6A;	GO:0050832~defense response to fungus	7	28	25	0.00076547253191161	0.0464826596102191	1	1	0.965260862740547	0.9999999954262	0.374238245591028
down	PCDHB10; PCDHGB4; PCDHB5; CDH18; CDH15; CDH10;	GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	6	45	13.3333333333333	0.00077052075703842	0.0206217867125661	1	1	0.65284669574611	0.999492318039222	0.173162232633338
down	PITX3; GLI2; LIF; EPHA5; EN1; ISL2;	GO:0048666~neuron development	6	47	12.7659574468085	0.00094715981469728	0.0249090342821357	1	1	0.716999979725845	0.999492318039222	0.209162477003343
down	COL6A1; COL14A1; COL6A3; COL6A2;	GO:0003429~growth plate cartilage chondrocyte morphogenesis	4	17	23.5294117647059	0.00095072649931815	0.0249090342821357	1	1	0.717798506985207	0.999492318039222	0.209162477003343
up	CD1C; CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	4	7	57.1428571428571	0.00100090945888565	0.0587533852365874	1	1	0.9999999954262	0.9999999954262	0.473031534723979
down	GIP; NTF4; GDNF; CXCL12; EN1; PREX2;	GO:0008344~adult locomotory behavior	6	48	12.5	0.00104637866154822	0.0271295467561825	1	1	0.737696956391495	0.999492318039222	0.227808237574701
down	SCT; AQP1; SCTR;	GO:0009992~cellular water homeostasis	3	7	42.8571428571429	0.00106287125919291	0.0272730573621768	1	1	0.740821267657458	0.999492318039222	0.229013303716007
down	GREM1; NR2F2; COMP; MEOX2; SALL1;	GO:0060173~limb development	5	32	15.625	0.00112267816115841	0.0285137341135028	1	1	0.752634416651302	0.999492318039222	0.239431331951406
down	FXYD1; CHRM2; DES; TBX2; HSPB7;	GO:0008016~regulation of heart contraction	5	33	15.1515151515152	0.00127009796051669	0.0309928806247652	1	1	0.781423711277308	0.999492318039222	0.260248856198892
down	EN1; TWIST1; OSR2; OSR1; TBX5;	GO:0035115~embryonic forelimb morphogenesis	5	33	15.1515151515152	0.00127009796051669	0.0309928806247652	1	1	0.781423711277308	0.999492318039222	0.260248856198892
down	SAA1; CCL8; CCL2; CCL11; CCL13;	GO:0048247~lymphocyte chemotaxis	5	33	15.1515151515152	0.00127009796051669	0.0309928806247652	1	1	0.781423711277308	0.999492318039222	0.260248856198892
down	AGT; IGF1; MMP2; FGF2; HTR1B;	GO:1904707~positive regulation of vascular smooth muscle cell proliferation	5	33	15.1515151515152	0.00127009796051669	0.0309928806247652	1	1	0.781423711277308	0.999492318039222	0.260248856198892
down	FZD7; PITX3; AGT; COL1A1; APOE; IGF1; FGF2; GLI2; FGF7; NR2F2; FOXL2; HAND2; ESRRG; ACTA2; FOXF1; FOXF2; GDF6; SCX; OSR2; ATOH8; TBX5; FOXC2; MESP1; EBF3; SALL1;	GO:0045893~positive regulation of transcription, DNA-templated	25	570	4.3859649122807	0.00134847357405765	0.0322363463329972	1	1	0.796947882268072	0.999492318039222	0.270690303452793
down	DLX2; OSR2; OSR1; CDX1;	GO:0009790~embryo development	4	19	21.0526315789474	0.00135940621726927	0.0322363463329972	1	1	0.799183341079065	0.999492318039222	0.270690303452793
down	CXCL11; CXCL12; GPR17; CCL2; CCL11; CCL13; CCL8;	GO:0070098~chemokine-mediated signaling pathway	7	70	10	0.00135991015064874	0.0322363463329972	1	1	0.799183341079065	0.999492318039222	0.270690303452793
down	SCX; TCF21; HAND2; TWIST1; COLEC10;	GO:0032502~developmental process	5	34	14.7058823529412	0.00143132972995297	0.0331431481420437	1	1	0.812995286613286	0.999492318039222	0.278304766156685
down	COL3A1; COL5A2; COL5A1; COMP; COL1A1;	GO:0043588~skin development	5	34	14.7058823529412	0.00143132972995297	0.0331431481420437	1	1	0.812995286613286	0.999492318039222	0.278304766156685
down	DRD2; HTR1B; EN1;	GO:0042756~drinking behavior	3	8	37.5	0.00143811169117747	0.0331431481420437	1	1	0.814262272042821	0.999492318039222	0.278304766156685
up	AIRE; S100A8; S100A9;	GO:0032602~chemokine production	3	3	100	0.00158746334434723	0.0822212632175138	1	1	0.9999999954262	0.9999999954262	0.661974627846718
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.00158746334434723	0.0822212632175138	1	1	0.9999999954262	0.9999999954262	0.661974627846718
down	AGT; IGF1; ADRA1A; HAND2;	GO:0010613~positive regulation of cardiac muscle hypertrophy	4	20	20	0.0016037024492469	0.0357157528480064	1	1	0.841943785854624	0.999492318039222	0.299907063803186
down	GREM1; GLI2; GDF5; ADAMTS12;	GO:0032331~negative regulation of chondrocyte differentiation	4	20	20	0.0016037024492469	0.0357157528480064	1	1	0.841943785854624	0.999492318039222	0.299907063803186
down	CCL11; CCL13; CCL8; CCL2;	GO:0048245~eosinophil chemotaxis	4	20	20	0.0016037024492469	0.0357157528480064	1	1	0.841943785854624	0.999492318039222	0.299907063803186
down	PITX3; DRD2; HTR1B; TACR3; RGS4;	GO:0042220~response to cocaine	5	35	14.2857142857143	0.00160713713096694	0.0357157528480064	1	1	0.842431825481665	0.999492318039222	0.299907063803186
down	APOE; CXCL12; CCL11; CCL8; GRIK2; RGN; CCL13; STC2;	GO:0006874~cellular calcium ion homeostasis	8	94	8.51063829787234	0.00165202513309215	0.0363884120023572	1	1	0.848103725396157	0.999492318039222	0.305555418264037
up	IL2RA; CTLA4; IL10; CLEC4G; LILRB2; LILRB1; FOXJ1; CD80;	GO:0042130~negative regulation of T cell proliferation	8	43	18.6046511627907	0.00174597635070572	0.0878475529597938	1	1	0.9999999954262	0.9999999954262	0.707272655541217
down	AGT; FGF1; ANGPT1; CCBE1; ATOH8; FOXC2;	GO:0010595~positive regulation of endothelial cell migration	6	54	11.1111111111111	0.00181924532010969	0.0391190354099367	1	1	0.869137812125155	0.999492318039222	0.328484607297361
down	COL3A1; ITGA8; ADAMTS12; NID2; FERMT2; ITGA11; EMILIN1; ITGBL1;	GO:0007160~cell-matrix adhesion	8	96	8.33333333333333	0.00186919733443669	0.0391190354099367	1	1	0.875084221818163	0.999492318039222	0.328484607297361
down	LEFTY2; LEFTY1; COL3A1; COL1A2; GDF5; LTBP2; WFIKKN2; FERMT2;	GO:0007179~transforming growth factor beta receptor signaling pathway	8	96	8.33333333333333	0.00186919733443669	0.0391190354099367	1	1	0.875084221818163	0.999492318039222	0.328484607297361
down	PLPP3; COL3A1; THY1; FBLN1; ITGA8; FERMT2; ITGA11; ITGBL1;	GO:0007229~integrin-mediated signaling pathway	8	96	8.33333333333333	0.00186919733443669	0.0391190354099367	1	1	0.875084221818163	0.999492318039222	0.328484607297361
down	CLDN11; CLDN14; CLDN6; CLDN18;	GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	4	21	19.047619047619	0.00187691070841212	0.0391190354099367	1	1	0.876448148148009	0.999492318039222	0.328484607297361
down	LOX; MFAP4; EMILIN1;	GO:0048251~elastic fiber assembly	3	9	33.3333333333333	0.00188689814929033	0.0391190354099367	1	1	0.877407639420003	0.999492318039222	0.328484607297361
down	FGF10; FZD7; MMP12;	GO:0060054~positive regulation of epithelial cell proliferation involved in wound healing	3	9	33.3333333333333	0.00188689814929033	0.0391190354099367	1	1	0.877407639420003	0.999492318039222	0.328484607297361
up	FCN1; SIGLEC5; TYROBP; FCGR3B; TRPM2; HP; ORM1; LTF; S100A8; S100A9; CTSG; RNASE2; FCGR2A; RNASE3; DEFA4; BPI; CD53; ORM2; AZU1; MMP8; FCAR; CXCR1; CEACAM8; CEACAM3; MNDA; P2RX1; HK3; CRISP3; NCKAP1L; S100A12; SIGLEC14; CLEC12A; LILRB2; CLEC4C; MS4A3; ADGRE3; RETN; CD300A;	GO:0043312~neutrophil degranulation	38	483	7.86749482401656	0.00219923976313574	0.10757947841339	1	1	0.9999999954262	0.9999999954262	0.866137084250957
down	KCNK2; COL3A1; DCN; GDF5; PIEZO2; COL1A1;	GO:0009612~response to mechanical stimulus	6	57	10.5263157894737	0.00233859373233869	0.0477111458999262	1	1	0.924696584615921	0.999492318039222	0.400633013069218
up	LILRA5; ORM1; LPL; ORM2; LILRA2; TLR8; NLRP7;	GO:0050718~positive regulation of interleukin-1 beta secretion	7	35	20	0.00234197922001267	0.109207989334219	1	1	0.9999999954262	0.9999999954262	0.879248448253093
down	IGFBP3; IGFBP4; NKX6-1;	GO:0044342~type B pancreatic cell proliferation	3	10	30	0.00241388621107874	0.047802564066905	1	1	0.930995189076523	0.999492318039222	0.401400656247666
down	HOXC11; OSR2; OSR1;	GO:0060272~embryonic skeletal joint morphogenesis	3	10	30	0.00241388621107874	0.047802564066905	1	1	0.930995189076523	0.999492318039222	0.401400656247666
up	TRPM2; CXCR1; CCR2; CCR5; CCR6;	GO:0002407~dendritic cell chemotaxis	5	17	29.4117647058824	0.00241857557298952	0.109207989334219	1	1	0.9999999954262	0.9999999954262	0.879248448253093
down	LEFTY2; ISLR; VEGFD; SERPINA3; IGF2; IGF1; CLEC3B; TIMP3; RARRES2;	GO:0002576~platelet degranulation	9	124	7.25806451612903	0.00241989677478105	0.047802564066905	1	1	0.931647915743397	0.999492318039222	0.401400656247666
down	GREM1; SP9; GDF5; TBX5; TBX4;	GO:0030326~embryonic limb morphogenesis	5	39	12.8205128205128	0.00247164121591537	0.0484402754835696	1	1	0.935656580525817	0.999492318039222	0.406755552708607
down	APOE; SVEP1; MESP1; NOX4;	GO:0010467~gene expression	4	23	17.3913043478261	0.00251678396687038	0.0489396507307843	1	1	0.939122977298285	0.999492318039222	0.410948833045311
up	TLR9; TLR8; TLR7;	GO:0045356~positive regulation of interferon-alpha biosynthetic process	3	4	75	0.00268614200329442	0.118257401695037	1	1	0.9999999954262	0.9999999954262	0.952106504008527
down	STC2; MMP2; LIF; FBLN1; PTGIS;	GO:0007566~embryo implantation	5	40	12.5	0.00273200858594802	0.0509320898818613	1	1	0.953627843143034	0.999492318039222	0.427679449872821
down	GPR37; PALM; HTR1B; ADCY8; ADCY2; GPR176;	GO:0007193~adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	6	59	10.1694915254237	0.0027420249273481	0.0509320898818613	1	1	0.954224674717138	0.999492318039222	0.427679449872821
down	APOE; EDNRB; AQP1; NPPB;	GO:0019934~cGMP-mediated signaling	4	24	16.6666666666667	0.0028867514798061	0.0526320011249548	1	1	0.961977087529143	0.999492318039222	0.441953694400489
down	FGF10; ISL1; NKX6-1; FOXF1;	GO:0031016~pancreas development	4	24	16.6666666666667	0.0028867514798061	0.0526320011249548	1	1	0.961977087529143	0.999492318039222	0.441953694400489
down	NGF; GLI2; ADRA2C; GDF5; FOXG1; NKX6-1; GDF6;	GO:0045666~positive regulation of neuron differentiation	7	81	8.64197530864197	0.00293140292783722	0.0528714629520786	1	1	0.963857611498014	0.999492318039222	0.443964468015461
down	FGF10; OSR2; OSR1;	GO:0001823~mesonephros development	3	11	27.2727272727273	0.00302332638244274	0.0537504240421427	1	1	0.967410601464734	0.999492318039222	0.451345150731017
down	NR0B1; OSR1; SALL1;	GO:0008406~gonad development	3	11	27.2727272727273	0.00302332638244274	0.0537504240421427	1	1	0.967410601464734	0.999492318039222	0.451345150731017
up	IFNG; C1QA; AZU1; AIF1; TLR8; TLR7;	GO:0001774~microglial cell activation	6	27	22.2222222222222	0.00302649240328934	0.127596284518173	1	1	0.9999999954262	0.9999999954262	1
down	FGF10; COL3A1; FGF1; DCN; FGF2; PDGFRA; LOX;	GO:0042060~wound healing	7	82	8.53658536585366	0.00312369834927395	0.0547527126150906	1	1	0.971197854506183	0.999492318039222	0.459761420836691
down	MIF; PRELP; TBX2; NOX4;	GO:0007569~cell aging	4	25	16	0.00329222836955689	0.0559264519237744	1	1	0.977612301098906	0.999492318039222	0.469617371829402
down	SERPINB7; SCX; CREB3L1; LARP6;	GO:0032967~positive regulation of collagen biosynthetic process	4	25	16	0.00329222836955689	0.0559264519237744	1	1	0.977612301098906	0.999492318039222	0.469617371829402
down	CYP26A1; ADH1B; ADH1C; ADH1A;	GO:0042573~retinoic acid metabolic process	4	25	16	0.00329222836955689	0.0559264519237744	1	1	0.977612301098906	0.999492318039222	0.469617371829402
down	CTSV; STC2; LIF; PTGIS;	GO:0046697~decidualization	4	25	16	0.00329222836955689	0.0559264519237744	1	1	0.977612301098906	0.999492318039222	0.469617371829402
down	FXYD1; TPM2; DES; ACTA2; ACTG2; MYL7; SGCA; MYH13;	GO:0006936~muscle contraction	8	106	7.54716981132075	0.00331401287292643	0.0559264519237744	1	1	0.978097113922775	0.999492318039222	0.469617371829402
down	KCNK2; GIP; ADCY8; ITGA8; NTF3; NGF; NTF4;	GO:0007613~memory	7	83	8.43373493975904	0.00332547805733974	0.0559264519237744	1	1	0.978585699609086	0.999492318039222	0.469617371829402
up	HBA1; HBG2; HBZ; HBD; HBM; HBG1;	GO:0042744~hydrogen peroxide catabolic process	6	28	21.4285714285714	0.00353860552504837	0.143659334664952	1	1	0.9999999954262	0.9999999954262	1
up	S100A8; S100A9; CCR6; FUT7;	GO:0002523~leukocyte migration involved in inflammatory response	4	11	36.3636363636364	0.00358944390985683	0.143659334664952	1	1	0.9999999954262	0.9999999954262	1
down	FOXS1; COL1A1; COL1A2; COL5A1; FOXF1;	GO:0001568~blood vessel development	5	43	11.6279069767442	0.00363192986778316	0.0602658229394152	1	1	0.990386603249522	0.999492318039222	0.506055299530151
down	MMP2; MMP3; COL15A1; MMP12; MMP23B;	GO:0030574~collagen catabolic process	5	43	11.6279069767442	0.00363192986778316	0.0602658229394152	1	1	0.990386603249522	0.999492318039222	0.506055299530151
down	AKR1B10; ADH1B; APOE; RBP1; RARRES2; GPC6;	GO:0001523~retinoid metabolic process	6	63	9.52380952380952	0.00370242744276883	0.0605019450364016	1	1	0.992773720318071	0.999492318039222	0.508038029254696
down	ADH1B; ADH1C; ADH1A;	GO:0006069~ethanol oxidation	3	12	25	0.00371908300143409	0.0605019450364016	1	1	0.993383473047537	0.999492318039222	0.508038029254696
down	ADRA1A; CACNA2D1; JPH2;	GO:0060402~calcium ion transport into cytosol	3	12	25	0.00371908300143409	0.0605019450364016	1	1	0.993383473047537	0.999492318039222	0.508038029254696
up	SPTA1; HLA-DMB; CD40LG; AIF1; NCKAP1L; CLECL1; LILRB2; CD209; CD80;	GO:0042102~positive regulation of T cell proliferation	9	61	14.7540983606557	0.00377482008212393	0.147721292547116	1	1	0.9999999954262	0.9999999954262	1
down	NUPR1; GREM1; NGF; IGF1; GLI2; MIF; EDNRB; AQP1; GDNF; PTGFR; COMP; ACTC1; ANGPT1; RGN; TWIST1; ASIC2; SCX; OSR1; BIRC7; FAIM2; FMN2;	GO:0043066~negative regulation of apoptotic process	21	489	4.29447852760736	0.00393565756628655	0.0634079651105905	1	1	0.999492318039222	0.999492318039222	0.532440033365097
down	CLEC3B; COL1A2; LOX; COMP; TUFT1;	GO:0030282~bone mineralization	5	44	11.3636363636364	0.00397414325321499	0.0634079651105905	1	1	0.999492318039222	0.999492318039222	0.532440033365097
down	AKR1B15; AKR1B10; ADH1C; ADH1A; ADH1B;	GO:0042572~retinol metabolic process	5	44	11.3636363636364	0.00397414325321499	0.0634079651105905	1	1	0.999492318039222	0.999492318039222	0.532440033365097
up	ORM1; BPI; IL10; NCKAP1L; SLAMF1; TLR9;	GO:0032715~negative regulation of interleukin-6 production	6	29	20.6896551724138	0.00411235717880742	0.155715785024229	1	1	0.9999999954262	0.9999999954262	1
up	CNR2; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.00415595791944279	0.155715785024229	1	1	0.9999999954262	0.9999999954262	1
down	STC2; KCNK2; AQP1; TWIST1; PTGIS; COX4I2; FMN2; KCND2;	GO:0071456~cellular response to hypoxia	8	111	7.20720720720721	0.00430291880898548	0.0640690281234509	1	1	0.999492318039222	0.999492318039222	0.53799101441314
down	FGF2; PDGFRA; NTF3;	GO:0010863~positive regulation of phospholipase C activity	3	13	23.0769230769231	0.00450465243937481	0.0640690281234509	1	1	0.999492318039222	0.999492318039222	0.53799101441314
down	CCL2; AQP1; ABCA12;	GO:0019725~cellular homeostasis	3	13	23.0769230769231	0.00450465243937481	0.0640690281234509	1	1	0.999492318039222	0.999492318039222	0.53799101441314
down	NGF; NTF4; NTF3;	GO:0038180~nerve growth factor signaling pathway	3	13	23.0769230769231	0.00450465243937481	0.0640690281234509	1	1	0.999492318039222	0.999492318039222	0.53799101441314
down	IGF1; IGFBP3; IGFBP4;	GO:0043568~positive regulation of insulin-like growth factor receptor signaling pathway	3	13	23.0769230769231	0.00450465243937481	0.0640690281234509	1	1	0.999492318039222	0.999492318039222	0.53799101441314
down	FGF10; FOXF1; NFATC4;	GO:0051145~smooth muscle cell differentiation	3	13	23.0769230769231	0.00450465243937481	0.0640690281234509	1	1	0.999492318039222	0.999492318039222	0.53799101441314
down	FOXF1; FOXC2; MESP2; TBX18; MESP1;	GO:0001756~somitogenesis	5	46	10.8695652173913	0.00472664223407671	0.0653487424426376	1	1	0.999492318039222	0.999492318039222	0.54873684316852
down	ISL1; TBX2; ZFPM2; ROBO2;	GO:0003148~outflow tract septum morphogenesis	4	28	14.2857142857143	0.00473730166172959	0.0653487424426376	1	1	0.999492318039222	0.999492318039222	0.54873684316852
down	PENK; COL3A1; CXCL12; CCL11;	GO:0009314~response to radiation	4	28	14.2857142857143	0.00473730166172959	0.0653487424426376	1	1	0.999492318039222	0.999492318039222	0.54873684316852
down	FGF10; GLI2; FGF7; KRT17;	GO:0031069~hair follicle morphogenesis	4	28	14.2857142857143	0.00473730166172959	0.0653487424426376	1	1	0.999492318039222	0.999492318039222	0.54873684316852
down	MMP2; COL11A1; COL6A1; COL8A1;	GO:0035987~endodermal cell differentiation	4	28	14.2857142857143	0.00473730166172959	0.0653487424426376	1	1	0.999492318039222	0.999492318039222	0.54873684316852
down	IGF1; COL6A3; SGCG; TWIST1; SGCA; SGCD; ITGA11;	GO:0007517~muscle organ development	7	89	7.86516853932584	0.00475215845002708	0.0653487424426376	1	1	0.999492318039222	0.999492318039222	0.54873684316852
down	FGF18; COL1A1; TMEM119; SCX;	GO:0001958~endochondral ossification	4	29	13.7931034482759	0.00530021342983322	0.0705196661537084	1	1	0.999492318039222	0.999492318039222	0.592157362790133
down	LUM; PRELP; FMOD; OMD;	GO:0018146~keratan sulfate biosynthetic process	4	29	13.7931034482759	0.00530021342983322	0.0705196661537084	1	1	0.999492318039222	0.999492318039222	0.592157362790133
down	ADRA2C; EDNRB; GRM1; TMEM100;	GO:0051930~regulation of sensory perception of pain	4	29	13.7931034482759	0.00530021342983322	0.0705196661537084	1	1	0.999492318039222	0.999492318039222	0.592157362790133
down	DRD2; NPPB; EDNRB;	GO:0035810~positive regulation of urine volume	3	14	21.4285714285714	0.00538318062242049	0.0705196661537084	1	1	0.999492318039222	0.999492318039222	0.592157362790133
down	TNFRSF11B; CLDN18; TMEM119;	GO:0045779~negative regulation of bone resorption	3	14	21.4285714285714	0.00538318062242049	0.0705196661537084	1	1	0.999492318039222	0.999492318039222	0.592157362790133
down	SAA1; CCL2; EDNRB;	GO:0048246~macrophage chemotaxis	3	14	21.4285714285714	0.00538318062242049	0.0705196661537084	1	1	0.999492318039222	0.999492318039222	0.592157362790133
down	MMP2; MMP3; MMP12;	GO:1904645~response to amyloid-beta	3	14	21.4285714285714	0.00538318062242049	0.0705196661537084	1	1	0.999492318039222	0.999492318039222	0.592157362790133
down	AGT; ROS1; IGFBP3; IGFBP4; PAPPA2; WFDC1;	GO:0001558~regulation of cell growth	6	69	8.69565217391304	0.00558230193951614	0.0720799119166533	1	1	0.999492318039222	0.999492318039222	0.60525882890139
down	FOXS1; NUPR1; NR0B1; HAND2; TWIST1; SFRP4;	GO:0043433~negative regulation of DNA-binding transcription factor activity	6	69	8.69565217391304	0.00558230193951614	0.0720799119166533	1	1	0.999492318039222	0.999492318039222	0.60525882890139
down	C1R; C8B; C1S; C7; C6; MASP1; COLEC10;	GO:0006956~complement activation	7	92	7.60869565217391	0.00561812089667768	0.0720799119166533	1	1	0.999492318039222	0.999492318039222	0.60525882890139
down	PIGR; THY1; GRIK2; TMEFF1;	GO:0043113~receptor clustering	4	30	13.3333333333333	0.00590613545361518	0.0728525978929865	1	1	0.999492318039222	0.999492318039222	0.611747113871614
down	CDX1; SFRP4; OSR2; PAPPA2;	GO:0060349~bone morphogenesis	4	30	13.3333333333333	0.00590613545361518	0.0728525978929865	1	1	0.999492318039222	0.999492318039222	0.611747113871614
down	FGF10; AGT; IGF1; CCL11;	GO:0070371~ERK1 and ERK2 cascade	4	30	13.3333333333333	0.00590613545361518	0.0728525978929865	1	1	0.999492318039222	0.999492318039222	0.611747113871614
down	VGLL3; APOE; HOXD11; ID4; MESP2; KLF17; ATOH7; ZBTB8B; ISL2; PITX2; PRRX2; HIF3A; DLX2; BARX1; SCX; SP9; FOXC2; FOXL2; EN1; NR2F1; TWIST1; KLF15; FOXS1; TCF21; CDX1; HAND2; NPAS4; NR2F2;	GO:0006357~regulation of transcription by RNA polymerase II	28	747	3.7483266398929	0.00602645725118123	0.0728525978929865	1	1	0.999492318039222	0.999492318039222	0.611747113871614
up	CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	3	6	50	0.00602864660112368	0.200310314426015	1	1	0.9999999954262	0.9999999954262	1
up	APOA2; IL10; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	3	6	50	0.00602864660112368	0.200310314426015	1	1	0.9999999954262	0.9999999954262	1
up	PF4; SPI1; IL10;	GO:0045347~negative regulation of MHC class II biosynthetic process	3	6	50	0.00602864660112368	0.200310314426015	1	1	0.9999999954262	0.9999999954262	1
down	GABRA2; SLC6A7; SLC6A14;	GO:0006836~neurotransmitter transport	3	15	20	0.00635747989597923	0.0728525978929865	1	1	0.999492318039222	0.999492318039222	0.611747113871614
down	GFRA3; GDNF; HAND2;	GO:0048485~sympathetic nervous system development	3	15	20	0.00635747989597923	0.0728525978929865	1	1	0.999492318039222	0.999492318039222	0.611747113871614
down	DRD2; HTR1B; GRIK2;	GO:0051967~negative regulation of synaptic transmission, glutamatergic	3	15	20	0.00635747989597923	0.0728525978929865	1	1	0.999492318039222	0.999492318039222	0.611747113871614
down	NKX6-1; UNC5D; SCRT1;	GO:2001222~regulation of neuron migration	3	15	20	0.00635747989597923	0.0728525978929865	1	1	0.999492318039222	0.999492318039222	0.611747113871614
down	DCN; ELN; NR2F2; MEOX2; POPDC3;	GO:0007519~skeletal muscle tissue development	5	50	10	0.00652557337929838	0.0728525978929865	1	1	0.999492318039222	0.999492318039222	0.611747113871614
down	SCT; SCTR; NPAS4; FGF14; RIMS4;	GO:0048167~regulation of synaptic plasticity	5	50	10	0.00652557337929838	0.0728525978929865	1	1	0.999492318039222	0.999492318039222	0.611747113871614
down	CHRM2; DRD2; HTR1B; ADRA1A; RIMS4;	GO:2000300~regulation of synaptic vesicle exocytosis	5	50	10	0.00652557337929838	0.0728525978929865	1	1	0.999492318039222	0.999492318039222	0.611747113871614
down	APOE; NR2F2; ATOH8; TNMD;	GO:0001937~negative regulation of endothelial cell proliferation	4	31	12.9032258064516	0.00655644111210485	0.0728525978929865	1	1	0.999492318039222	0.999492318039222	0.611747113871614
down	COL1A1; MMP2; PDGFRA; SCX;	GO:0060325~face morphogenesis	4	31	12.9032258064516	0.00655644111210485	0.0728525978929865	1	1	0.999492318039222	0.999492318039222	0.611747113871614
up	ABRA; GPR55; GPR174; GPR65; F2RL3; P2RY10;	GO:0035025~positive regulation of Rho protein signal transduction	6	33	18.1818181818182	0.00710923557547738	0.22749555495074	1	1	0.9999999954262	0.9999999954262	1
up	P2RY10; GPR171; P2RY13; P2RY12;	GO:0035589~G protein-coupled purinergic nucleotide receptor signaling pathway	4	14	28.5714285714286	0.00723438448452096	0.22749555495074	1	1	0.9999999954262	0.9999999954262	1
up	IL27; TLR9; TLR8; TLR7;	GO:0045078~positive regulation of interferon-gamma biosynthetic process	4	14	28.5714285714286	0.00723438448452096	0.22749555495074	1	1	0.9999999954262	0.9999999954262	1
down	ANGPT1; CCBE1; RSPO3; VEGFD;	GO:0002040~sprouting angiogenesis	4	32	12.5	0.00725245678098596	0.0795214314003262	1	1	0.999492318039222	0.999492318039222	0.667745661198615
down	IGF1; FGF1; ADRA2C; NTF3;	GO:0032148~activation of protein kinase B activity	4	32	12.5	0.00725245678098596	0.0795214314003262	1	1	0.999492318039222	0.999492318039222	0.667745661198615
down	PDGFRA; DLX2; TWIST1; SIX2;	GO:0048701~embryonic cranial skeleton morphogenesis	4	32	12.5	0.00725245678098596	0.0795214314003262	1	1	0.999492318039222	0.999492318039222	0.667745661198615
down	IGF1; HAND2; TWIST1;	GO:2000679~positive regulation of transcription regulatory region DNA binding	3	16	18.75	0.00743004525335511	0.0811113273491266	1	1	0.999492318039222	0.999492318039222	0.681096101487148
down	FOXS1; IGF2; DRD2; DIO3;	GO:0040018~positive regulation of multicellular organism growth	4	33	12.1212121212121	0.00799546024997388	0.0865247850529783	1	1	0.999492318039222	0.999492318039222	0.726553191861081
down	FGF10; TCF21; PITX2; BARX1;	GO:0048536~spleen development	4	33	12.1212121212121	0.00799546024997388	0.0865247850529783	1	1	0.999492318039222	0.999492318039222	0.726553191861081
down	HOXC11; GLI2; NR2F2; HOXC8; BARX1; HOXC9; HES2;	GO:0009952~anterior/posterior pattern specification	7	99	7.07070707070707	0.00809242969542345	0.0871950541641081	1	1	0.999492318039222	0.999492318039222	0.732181477002722
down	KCNU1; ABCC9; KCNK2; AQP1; KCNJ8; NALCN; KCND2; KCNK9;	GO:0071805~potassium ion transmembrane transport	8	125	6.4	0.00829131026228147	0.0881319138772768	1	1	0.999492318039222	0.999492318039222	0.740048337515718
up	BPI; IL10; TLR9;	GO:0032717~negative regulation of interleukin-8 production	3	7	42.8571428571429	0.00832941890036087	0.243362095765148	1	1	0.9999999954262	0.9999999954262	1
up	FCGR2B; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	3	7	42.8571428571429	0.00832941890036087	0.243362095765148	1	1	0.9999999954262	0.9999999954262	1
up	HP; GZMA; GZMK;	GO:0051354~negative regulation of oxidoreductase activity	3	7	42.8571428571429	0.00832941890036087	0.243362095765148	1	1	0.9999999954262	0.9999999954262	1
up	PF4; IL10; CXCR5; CNR2; PF4V1;	GO:0030595~leukocyte chemotaxis	5	24	20.8333333333333	0.00842991927409087	0.243362095765148	1	1	0.9999999954262	0.9999999954262	1
up	PF4; IL10; IRF8; IRF4; BATF;	GO:0042832~defense response to protozoan	5	24	20.8333333333333	0.00842991927409087	0.243362095765148	1	1	0.9999999954262	0.9999999954262	1
down	SAA1; CCL8; CCL13; CCL11; CXCL11; CCL2;	GO:0030593~neutrophil chemotaxis	6	76	7.89473684210526	0.00856172274921119	0.0881319138772768	1	1	0.999492318039222	0.999492318039222	0.740048337515718
down	FGF18; COL11A1; COMP;	GO:0002063~chondrocyte development	3	17	17.6470588235294	0.00860306995030358	0.0881319138772768	1	1	0.999492318039222	0.999492318039222	0.740048337515718
down	C8B; C7; C6;	GO:0019835~cytolysis	3	17	17.6470588235294	0.00860306995030358	0.0881319138772768	1	1	0.999492318039222	0.999492318039222	0.740048337515718
down	GRM6; CCL2; CXCL12;	GO:0090280~positive regulation of calcium ion import	3	17	17.6470588235294	0.00860306995030358	0.0881319138772768	1	1	0.999492318039222	0.999492318039222	0.740048337515718
up	LTF; MS4A1; CCR2; CCR6; FOXJ1; JCHAIN; IFNG; AIRE;	GO:0006959~humoral immune response	8	58	13.7931034482759	0.00877316021299357	0.247247247294762	1	1	0.9999999954262	0.9999999954262	1
down	TBX18; TBX5; TBX4; TBX2;	GO:0001708~cell fate specification	4	34	11.7647058823529	0.00878667934292143	0.0881319138772768	1	1	0.999492318039222	0.999492318039222	0.740048337515718
down	ATP6V1B1; AQP1; ADCY8; ADCY2;	GO:0003091~renal water homeostasis	4	34	11.7647058823529	0.00878667934292143	0.0881319138772768	1	1	0.999492318039222	0.999492318039222	0.740048337515718
down	TCF21; LIF; FOXF1; ABCA12;	GO:0048286~lung alveolus development	4	34	11.7647058823529	0.00878667934292143	0.0881319138772768	1	1	0.999492318039222	0.999492318039222	0.740048337515718
up	APOA2; TLR8; TLR7; TLR9;	GO:0045416~positive regulation of interleukin-8 biosynthetic process	4	15	26.6666666666667	0.0088453018623339	0.247247247294762	1	1	0.9999999954262	0.9999999954262	1
down	FOXS1; GREM1; NR2F2; ID4; NR0B1; FOXG1; FOXL2; FOXF2; TBX2; TWIST1; NKAPL; ERN2; SCX; ZFPM2; CREB3L1; ATOH8; MESP1; TCEAL7; SALL1; MAGEL2; SIX2;	GO:0045892~negative regulation of transcription, DNA-templated	21	530	3.9622641509434	0.0091398389584697	0.088863512373559	1	1	0.999492318039222	0.999492318039222	0.746191608744986
down	ASIC2; RIMS4; POPDC3; GABRG3; GABRR3; GABRA2; PIEZO2;	GO:0042391~regulation of membrane potential	7	102	6.86274509803922	0.00936763023523357	0.0907238585816979	1	1	0.999492318039222	0.999492318039222	0.761813034151156
down	CXCL11; LHCGR; ADCY8; ADCY2; PTGFR; PTGER1; ADGRL2;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	7	103	6.79611650485437	0.00982361651310215	0.0934885484711863	1	1	0.999492318039222	0.999492318039222	0.785028281233064
down	ISL1; TBX2; TWIST1;	GO:0003203~endocardial cushion morphogenesis	3	18	16.6666666666667	0.00987846052548091	0.0934885484711863	1	1	0.999492318039222	0.999492318039222	0.785028281233064
down	ISL1; ISL2; ROBO2;	GO:0031290~retinal ganglion cell axon guidance	3	18	16.6666666666667	0.00987846052548091	0.0934885484711863	1	1	0.999492318039222	0.999492318039222	0.785028281233064
down	GRIK2; KISS1; RIMS4;	GO:0050806~positive regulation of synaptic transmission	3	18	16.6666666666667	0.00987846052548091	0.0934885484711863	1	1	0.999492318039222	0.999492318039222	0.785028281233064
down	GREM1; AGT; GDNF;	GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis	3	18	16.6666666666667	0.00987846052548091	0.0934885484711863	1	1	0.999492318039222	0.999492318039222	0.785028281233064
down	FGF1; FGF2; BMPER;	GO:1903672~positive regulation of sprouting angiogenesis	3	18	16.6666666666667	0.00987846052548091	0.0934885484711863	1	1	0.999492318039222	0.999492318039222	0.785028281233064
down	FGF10; FGF18; FGF1; FGF2; FGF5; FGF7;	GO:0008543~fibroblast growth factor receptor signaling pathway	6	79	7.59493670886076	0.0101345980794495	0.0955492978020826	1	1	0.999492318039222	0.999492318039222	0.802332502249869
down	RSPO4; RSPO1; RSPO3; SALL1;	GO:0030177~positive regulation of Wnt signaling pathway	4	36	11.1111111111111	0.0105184189045242	0.0987937534089085	1	1	0.999492318039222	0.999492318039222	0.82957636740998
up	TLR9; TLR8; TLR7;	GO:0045359~positive regulation of interferon-beta biosynthetic process	3	8	37.5	0.0110776099408869	0.253096291172166	1	1	0.9999999954262	0.9999999954262	1
up	LTF; DEFA4; DEFA3;	GO:0051673~membrane disruption in other organism	3	8	37.5	0.0110776099408869	0.253096291172166	1	1	0.9999999954262	0.9999999954262	1
up	C1QA; C1QB; C1QC;	GO:0098883~synapse pruning	3	8	37.5	0.0110776099408869	0.253096291172166	1	1	0.9999999954262	0.9999999954262	1
up	IFNG; CD40LG; IRF8; SCIMP; TLR9;	GO:0032735~positive regulation of interleukin-12 production	5	26	19.2307692307692	0.0112103979054111	0.253096291172166	1	1	0.9999999954262	0.9999999954262	1
down	AGT; APOE; MT1M;	GO:0007263~nitric oxide mediated signal transduction	3	19	15.7894736842105	0.0112578512464134	0.103947922699418	1	1	0.999492318039222	0.999492318039222	0.872856199276876
down	PDGFRA; BMP5; LHCGR;	GO:0030539~male genitalia development	3	19	15.7894736842105	0.0112578512464134	0.103947922699418	1	1	0.999492318039222	0.999492318039222	0.872856199276876
down	FGF18; GDF5; GDF6;	GO:0032332~positive regulation of chondrocyte differentiation	3	19	15.7894736842105	0.0112578512464134	0.103947922699418	1	1	0.999492318039222	0.999492318039222	0.872856199276876
down	AGT; APOE; EDNRB;	GO:0042311~vasodilation	3	19	15.7894736842105	0.0112578512464134	0.103947922699418	1	1	0.999492318039222	0.999492318039222	0.872856199276876
down	CCL2; ADAMTS12; PTGIS; CCL8; CCL13; CCL11;	GO:0071347~cellular response to interleukin-1	6	81	7.40740740740741	0.0112907726943481	0.103947922699418	1	1	0.999492318039222	0.999492318039222	0.872856199276876
up	LILRA5; IFNG; LPL; AIF1; LILRA2; TLR8;	GO:2000778~positive regulation of interleukin-6 secretion	6	37	16.2162162162162	0.0114324946806857	0.254843330793514	1	1	0.9999999954262	0.9999999954262	1
down	FXYD1; ANO4; SLC26A9; CLCNKB;	GO:0006821~chloride transport	4	37	10.8108108108108	0.0114611353695259	0.103947922699418	1	1	0.999492318039222	0.999492318039222	0.872856199276876
down	IGF2; EDNRB; THPO; ANGPT1; RSPO1; TMEM119; CLIP3; RARRES2; VEGFD;	GO:0001934~positive regulation of protein phosphorylation	9	161	5.59006211180124	0.0117020995858725	0.103947922699418	1	1	0.999492318039222	0.999492318039222	0.872856199276876
up	POMC; ORM1; BPI; IL10; LILRA4; SLAMF1; CLEC4A;	GO:0032720~negative regulation of tumor necrosis factor production	7	49	14.2857142857143	0.0117649205207898	0.258975312963886	1	1	0.9999999954262	0.9999999954262	1
down	KRT14; FGF7; NTF4; BNC1; SVEP1; KRTDAP;	GO:0008544~epidermis development	6	82	7.31707317073171	0.0119024338968799	0.103947922699418	1	1	0.999492318039222	0.999492318039222	0.872856199276876
down	FGF10; LEFTY1; FOXF1; ARMC4; PITX2;	GO:0007368~determination of left/right symmetry	5	59	8.47457627118644	0.0122220033769365	0.105995004896149	1	1	0.999492318039222	0.999492318039222	0.890045656645956
down	ZNF536; ID4; FOXG1; ISL1; ISL2;	GO:0045665~negative regulation of neuron differentiation	5	59	8.47457627118644	0.0122220033769365	0.105995004896149	1	1	0.999492318039222	0.999492318039222	0.890045656645956
down	LEFTY1; COL5A1; MESP2; MESP1;	GO:0003007~heart morphogenesis	4	38	10.5263157894737	0.0124564579286959	0.107280705136761	1	1	0.999492318039222	0.999492318039222	0.900841749499828
down	IGF1; CCL2; LOX; TMEM100;	GO:0043491~protein kinase B signaling	4	38	10.5263157894737	0.0124564579286959	0.107280705136761	1	1	0.999492318039222	0.999492318039222	0.900841749499828
down	FGF5; PDGFRA; MESP1;	GO:0023019~signal transduction involved in regulation of gene expression	3	20	15	0.0127426180007753	0.108617726725786	1	1	0.999492318039222	0.999492318039222	0.912068790428025
down	OSR2; OSR1; SIX2;	GO:0042474~middle ear morphogenesis	3	20	15	0.0127426180007753	0.108617726725786	1	1	0.999492318039222	0.999492318039222	0.912068790428025
down	AGT; DRD2; GRIK2;	GO:0048169~regulation of long-term neuronal synaptic plasticity	3	20	15	0.0127426180007753	0.108617726725786	1	1	0.999492318039222	0.999492318039222	0.912068790428025
down	AGT; LHCGR; EDNRB; ADRA1A; ADRA1B;	GO:0007200~phospholipase C-activating G protein-coupled receptor signaling pathway	5	60	8.33333333333333	0.0130120015810713	0.109786006560293	1	1	0.999492318039222	0.999492318039222	0.921878897927606
down	FGF18; FGF1; FGF2; MIF; NOX4;	GO:0043406~positive regulation of MAP kinase activity	5	60	8.33333333333333	0.0130120015810713	0.109786006560293	1	1	0.999492318039222	0.999492318039222	0.921878897927606
down	NUPR1; GDF5; ISL1; RGN; WFDC1;	GO:0050680~negative regulation of epithelial cell proliferation	5	60	8.33333333333333	0.0130120015810713	0.109786006560293	1	1	0.999492318039222	0.999492318039222	0.921878897927606
down	GRM1; KISS1; DRD2; GPR17;	GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	4	39	10.2564102564103	0.0135053501682003	0.113563569488684	1	1	0.999492318039222	0.999492318039222	0.95359929343507
down	AGT; COL1A2; NPPB; EDNRB; ACTA2;	GO:0008217~regulation of blood pressure	5	61	8.19672131147541	0.0138357519085472	0.115950122896882	1	1	0.999492318039222	0.999492318039222	0.973639308503718
down	PALM3; FGF10; PENK; DCN; PTGER1; PTGFR; LOXL1; GGT5;	GO:0032496~response to lipopolysaccharide	8	138	5.79710144927536	0.0140236187124536	0.117130157635225	1	1	0.999492318039222	0.999492318039222	0.98354812255191
up	HP; HBZ; HBD; S100A9; HBG1; HBG2; HBA1; HBM; LOXHD1;	GO:0098869~cellular oxidant detoxification	9	77	11.6883116883117	0.0142401161485655	0.29255692505106	1	1	0.9999999954262	0.9999999954262	1
up	CSF3; SPI1; CEBPE;	GO:0030851~granulocyte differentiation	3	9	33.3333333333333	0.0142872774300915	0.29255692505106	1	1	0.9999999954262	0.9999999954262	1
up	LY86; SCIMP; CD180;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	3	9	33.3333333333333	0.0142872774300915	0.29255692505106	1	1	0.9999999954262	0.9999999954262	1
up	IGHD; ORM1; ORM2;	GO:0050716~positive regulation of interleukin-1 secretion	3	9	33.3333333333333	0.0142872774300915	0.29255692505106	1	1	0.9999999954262	0.9999999954262	1
up	TYROBP; IFNG; AZU1;	GO:0050725~positive regulation of interleukin-1 beta biosynthetic process	3	9	33.3333333333333	0.0142872774300915	0.29255692505106	1	1	0.9999999954262	0.9999999954262	1
down	GREM1; FGF2; CLEC14A;	GO:0002042~cell migration involved in sprouting angiogenesis	3	21	14.2857142857143	0.014333891651015	0.117358737892685	1	1	0.999492318039222	0.999492318039222	0.985467523051458
down	HSPB6; NUPR1; HAND2;	GO:0010667~negative regulation of cardiac muscle cell apoptotic process	3	21	14.2857142857143	0.014333891651015	0.117358737892685	1	1	0.999492318039222	0.999492318039222	0.985467523051458
down	PDGFRA; NR0B1; SALL1;	GO:0030325~adrenal gland development	3	21	14.2857142857143	0.014333891651015	0.117358737892685	1	1	0.999492318039222	0.999492318039222	0.985467523051458
down	FZD7; SFRP4; FZD8;	GO:0035567~non-canonical Wnt signaling pathway	3	21	14.2857142857143	0.014333891651015	0.117358737892685	1	1	0.999492318039222	0.999492318039222	0.985467523051458
down	TBX5; MESP1; NOX4;	GO:0055007~cardiac muscle cell differentiation	3	21	14.2857142857143	0.014333891651015	0.117358737892685	1	1	0.999492318039222	0.999492318039222	0.985467523051458
down	VEGFD; PITX3; EN1;	GO:0071542~dopaminergic neuron differentiation	3	21	14.2857142857143	0.014333891651015	0.117358737892685	1	1	0.999492318039222	0.999492318039222	0.985467523051458
down	PALM; APOE; THY1; CCL2; DES; CCL11; KISS1; CCL13;	GO:0007010~cytoskeleton organization	8	139	5.75539568345324	0.0145601783399327	0.118440087057899	1	1	0.999492318039222	0.999492318039222	0.994547669127773
down	AGT; GIP; ADRA2C; PSG9; PSG4; PSG11;	GO:0007565~female pregnancy	6	86	6.97674418604651	0.0145826607005251	0.118440087057899	1	1	0.999492318039222	0.999492318039222	0.994547669127773
down	ADRB3; LHCGR; ADCY8; ADCY2;	GO:0007190~activation of adenylate cyclase activity	4	40	10	0.014608721063389	0.118440087057899	1	1	0.999492318039222	0.999492318039222	0.994547669127773
down	NGF; NYAP1; NTF3; NRK; NTF4;	GO:0048812~neuron projection morphogenesis	5	62	8.06451612903226	0.0146938435411003	0.11848767872671	1	1	0.999492318039222	0.999492318039222	0.994947298885411
up	SPI1; IRF4; BATF; BATF3;	GO:0043011~myeloid dendritic cell differentiation	4	18	22.2222222222222	0.0150194065251843	0.304013504492524	1	1	0.9999999954262	0.9999999954262	1
down	GRM6; PITX3; C1QL1; DRD2; ADCY8; GRM1;	GO:0007626~locomotory behavior	6	87	6.89655172413793	0.0153131398915711	0.119856620094719	1	1	0.999492318039222	0.999492318039222	1
down	AGT; IGF1; DCN; PDGFRA; NTF3; ANGPT1;	GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling	6	87	6.89655172413793	0.0153131398915711	0.119856620094719	1	1	0.999492318039222	0.999492318039222	1
up	CA6; TAS2R40; TAS2R41; TAS2R50; TAS2R13; RTP5;	GO:0001580~detection of chemical stimulus involved in sensory perception of bitter taste	6	40	15	0.0157018567597207	0.308163815316195	1	1	0.9999999954262	0.9999999954262	1
down	APOE; DCN; NR2F2;	GO:0010596~negative regulation of endothelial cell migration	3	22	13.6363636363636	0.0160325708704545	0.12431485637558	1	1	0.999492318039222	0.999492318039222	1
down	FBN1; ITGA11; ITGBL1;	GO:0033627~cell adhesion mediated by integrin	3	22	13.6363636363636	0.0160325708704545	0.12431485637558	1	1	0.999492318039222	0.999492318039222	1
down	ATP6V1B1; SGCD; JPH2;	GO:0055074~calcium ion homeostasis	3	22	13.6363636363636	0.0160325708704545	0.12431485637558	1	1	0.999492318039222	0.999492318039222	1
up	XCL1; CD1B; CD1C; CD1E; CD1A;	GO:0001916~positive regulation of T cell mediated cytotoxicity	5	29	17.2413793103448	0.0164569826040939	0.308163815316195	1	1	0.9999999954262	0.9999999954262	1
down	SCT; ID4; EPHA5; DLX2; CDK5R2;	GO:0021766~hippocampus development	5	64	7.8125	0.0165153182672031	0.127660332816983	1	1	0.999492318039222	0.999492318039222	1
down	KCNU1; CLCNKB; ASIC2; NALCN; CLIC6; KCND2; KCNJ8;	GO:0034765~regulation of ion transmembrane transport	7	115	6.08695652173913	0.016627169462288	0.128127011738808	1	1	0.999492318039222	0.999492318039222	1
down	ADRA1A; SFRP4; FOXC2; TIMP3;	GO:0009725~response to hormone	4	42	9.52380952380952	0.0169822602373001	0.13045940040321	1	1	0.999492318039222	0.999492318039222	1
down	CCL2; ADRB3; LHCGR; HTR1B; CHRM2;	GO:0007187~G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	5	65	7.69230769230769	0.0174797891764262	0.133868293108077	1	1	0.999492318039222	0.999492318039222	1
up	LTF; RNASE3; DEFA3; DEFA4;	GO:0002227~innate immune response in mucosa	4	19	21.0526315789474	0.017554372812524	0.308163815316195	1	1	0.9999999954262	0.9999999954262	1
down	APOE; CLIP3; CALY;	GO:0045807~positive regulation of endocytosis	3	23	13.0434782608696	0.0178393344786937	0.135372266821551	1	1	0.999492318039222	0.999492318039222	1
down	APOE; COMP; FOXC2;	GO:0048844~artery morphogenesis	3	23	13.0434782608696	0.0178393344786937	0.135372266821551	1	1	0.999492318039222	0.999492318039222	1
up	IL18RAP; AVPR2; LILRB1;	GO:0032609~interferon-gamma production	3	10	30	0.0179677528285676	0.308163815316195	1	1	0.9999999954262	0.9999999954262	1
up	IFNG; AZU1; IL10;	GO:0045348~positive regulation of MHC class II biosynthetic process	3	10	30	0.0179677528285676	0.308163815316195	1	1	0.9999999954262	0.9999999954262	1
up	FCRL3; TLR9; SLAMF8;	GO:0045577~regulation of B cell differentiation	3	10	30	0.0179677528285676	0.308163815316195	1	1	0.9999999954262	0.9999999954262	1
up	CLEC12B; LILRB1; KIR2DL4;	GO:0045953~negative regulation of natural killer cell mediated cytotoxicity	3	10	30	0.0179677528285676	0.308163815316195	1	1	0.9999999954262	0.9999999954262	1
up	CD3G; CD80; SLA; GRAP; CLNK; SKAP1; FCRL2; ROPN1B;	GO:0009967~positive regulation of signal transduction	8	67	11.9402985074627	0.0181993394621717	0.308163815316195	1	1	0.9999999954262	0.9999999954262	1
down	CDH15; CDH18; CADM3; CDH10;	GO:0034332~adherens junction organization	4	43	9.30232558139535	0.0182539716912813	0.13651260785822	1	1	0.999492318039222	0.999492318039222	1
down	CTSV; MMP2; MMP3; MMP12; ADAMTS5;	GO:0022617~extracellular matrix disassembly	5	66	7.57575757575758	0.018480776189288	0.13651260785822	1	1	0.999492318039222	0.999492318039222	1
down	CCL2; CCL13; CCL11; CCL8;	GO:0002548~monocyte chemotaxis	4	44	9.09090909090909	0.0195832482208858	0.143360896534661	1	1	0.999492318039222	0.999492318039222	1
down	COL11A1; PDGFRA; OSR2; HOXC9;	GO:0048704~embryonic skeletal system morphogenesis	4	44	9.09090909090909	0.0195832482208858	0.143360896534661	1	1	0.999492318039222	0.999492318039222	1
down	BMP5; DACT3; TBX5;	GO:0010719~negative regulation of epithelial to mesenchymal transition	3	24	12.5	0.0197546532925663	0.144191589575359	1	1	0.999492318039222	0.999492318039222	1
down	APOE; SAA1; ISL1; FOXF1; PTGIS; WFDC1;	GO:0050728~negative regulation of inflammatory response	6	93	6.45161290322581	0.0202331144848507	0.14702738856745	1	1	0.999492318039222	0.999492318039222	1
down	NTF3; NTF4; DDR2; EPHA5; NGF; PDGFRA; ROS1;	GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway	7	120	5.83333333333333	0.020261307464297	0.14702738856745	1	1	0.999492318039222	0.999492318039222	1
down	GREM1; APOE; IGFBP4; ISL1; SFRP4; NKD2; DACT3; CTHRC1; NOTUM;	GO:0090090~negative regulation of canonical Wnt signaling pathway	9	179	5.02793296089385	0.0211508444532315	0.153036197221201	1	1	0.999492318039222	0.999492318039222	1
down	FZD7; COL1A1; WNT2; AQP1; OSR1;	GO:0071300~cellular response to retinoic acid	5	69	7.2463768115942	0.0217076961896214	0.153707609515559	1	1	0.999492318039222	0.999492318039222	1
down	EDNRB; DRD2; PALM;	GO:0007194~negative regulation of adenylate cyclase activity	3	25	12	0.0217788015101358	0.153707609515559	1	1	0.999492318039222	0.999492318039222	1
down	COL11A1; ISL1; FOXC2;	GO:0055010~ventricular cardiac muscle tissue morphogenesis	3	25	12	0.0217788015101358	0.153707609515559	1	1	0.999492318039222	0.999492318039222	1
down	TRPA1; GIP; EDNRB; LUM;	GO:0014070~response to organic cyclic compound	4	46	8.69565217391304	0.0224169796119518	0.153707609515559	1	1	0.999492318039222	0.999492318039222	1
down	CXCL14; BMPER; C1QTNF5; CYTL1;	GO:0048839~inner ear development	4	46	8.69565217391304	0.0224169796119518	0.153707609515559	1	1	0.999492318039222	0.999492318039222	1
down	IL11; ID4; GDF6; GLIS1; CLIP3;	GO:0045444~fat cell differentiation	5	70	7.14285714285714	0.022859510064889	0.155883070004133	1	1	0.999492318039222	0.999492318039222	1
down	FZD7; WNT2; FZD8; SFRP4; PLPP3;	GO:0060070~canonical Wnt signaling pathway	5	70	7.14285714285714	0.022859510064889	0.155883070004133	1	1	0.999492318039222	0.999492318039222	1
up	FOLR2; CCR2; CCL23; S100A12; XCL2; XCL1;	GO:0002548~monocyte chemotaxis	6	44	13.6363636363636	0.0229520414724405	0.384938524123501	1	1	0.9999999954262	0.9999999954262	1
up	TYROBP; IFNG; AZU1; CCR2;	GO:0042535~positive regulation of tumor necrosis factor biosynthetic process	4	21	19.047619047619	0.023382330913974	0.388455516410455	1	1	0.9999999954262	0.9999999954262	1
down	AGT; DRD2; SHANK1;	GO:0008306~associative learning	3	26	11.5384615384615	0.0239118676417401	0.159204121637416	1	1	0.999492318039222	0.999492318039222	1
down	PLPP3; RSPO3; DACT3;	GO:0030111~regulation of Wnt signaling pathway	3	26	11.5384615384615	0.0239118676417401	0.159204121637416	1	1	0.999492318039222	0.999492318039222	1
down	DRD2; EN1; TYRP1;	GO:0043473~pigmentation	3	26	11.5384615384615	0.0239118676417401	0.159204121637416	1	1	0.999492318039222	0.999492318039222	1
down	NTF3; NGF; NTF4;	GO:0045664~regulation of neuron differentiation	3	26	11.5384615384615	0.0239118676417401	0.159204121637416	1	1	0.999492318039222	0.999492318039222	1
down	ADCY8; ADCY2; FGF21;	GO:0071377~cellular response to glucagon stimulus	3	26	11.5384615384615	0.0239118676417401	0.159204121637416	1	1	0.999492318039222	0.999492318039222	1
down	GREM1; HTRA3; BMPER; CHRDL1;	GO:0030514~negative regulation of BMP signaling pathway	4	47	8.51063829787234	0.0239225402398512	0.159204121637416	1	1	0.999492318039222	0.999492318039222	1
down	STC2; COL1A1; GIP; CXCL12;	GO:0043434~response to peptide hormone	4	47	8.51063829787234	0.0239225402398512	0.159204121637416	1	1	0.999492318039222	0.999492318039222	1
down	ABCC9; CACNA2D1; CACNG7; KCND2;	GO:0061337~cardiac conduction	4	47	8.51063829787234	0.0239225402398512	0.159204121637416	1	1	0.999492318039222	0.999492318039222	1
down	LAMA4; FOXC2; ADAMTS5; NOVA2;	GO:0120163~negative regulation of cold-induced thermogenesis	4	47	8.51063829787234	0.0239225402398512	0.159204121637416	1	1	0.999492318039222	0.999492318039222	1
down	PLPP3; DRD2; IGFBP3; FBLN1; ANGPT1;	GO:0001933~negative regulation of protein phosphorylation	5	71	7.04225352112676	0.0240501204241336	0.159204121637416	1	1	0.999492318039222	0.999492318039222	1
down	GRIK2; NTF3; NGF; GRIA1; NTF4;	GO:0050804~modulation of chemical synaptic transmission	5	71	7.04225352112676	0.0240501204241336	0.159204121637416	1	1	0.999492318039222	0.999492318039222	1
down	GABRR3; GABRA2; GABRG3;	GO:0007214~gamma-aminobutyric acid signaling pathway	3	27	11.1111111111111	0.0261537650059415	0.165692769698607	1	1	0.999492318039222	0.999492318039222	1
down	DDR2; TMEM119; AMTN;	GO:0031214~biomineral tissue development	3	27	11.1111111111111	0.0261537650059415	0.165692769698607	1	1	0.999492318039222	0.999492318039222	1
down	FGF10; FGF7; ANGPT1;	GO:0034394~protein localization to cell surface	3	27	11.1111111111111	0.0261537650059415	0.165692769698607	1	1	0.999492318039222	0.999492318039222	1
down	CDH18; CDH15; CDH10;	GO:0044331~cell-cell adhesion mediated by cadherin	3	27	11.1111111111111	0.0261537650059415	0.165692769698607	1	1	0.999492318039222	0.999492318039222	1
down	FGF2; WNT2; CXCL12; CCL11; VEGFD;	GO:0001938~positive regulation of endothelial cell proliferation	5	73	6.84931506849315	0.0265492884630417	0.166033113026409	1	1	0.999492318039222	0.999492318039222	1
up	IL10; SLAMF1; TIGIT;	GO:0032695~negative regulation of interleukin-12 production	3	12	25	0.0267578248125462	0.409743734738207	1	1	0.9999999954262	0.9999999954262	1
up	IL2RA; CTLA4; FCGR2B;	GO:0050777~negative regulation of immune response	3	12	25	0.0267578248125462	0.409743734738207	1	1	0.9999999954262	0.9999999954262	1
up	ADRA2A; AIF1; AVPR2; RAMP3; GPR150; AVPR1A;	GO:0032870~cellular response to hormone stimulus	6	46	13.0434782608696	0.0273021994592985	0.414475631446764	1	1	0.9999999954262	0.9999999954262	1
down	CXCL14; PDGFRA; LOX; CXCL12; SAA1;	GO:0060326~cell chemotaxis	5	74	6.75675675675676	0.0278585725430671	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	TWIST1; OSR2; OSR1;	GO:0035116~embryonic hindlimb morphogenesis	3	28	10.7142857142857	0.0285042418033669	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	COL3A1; CLDN18; FOXF1;	GO:0048565~digestive tract development	3	28	10.7142857142857	0.0285042418033669	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	AGT; RGS4; CACNA2D1;	GO:0051924~regulation of calcium ion transport	3	28	10.7142857142857	0.0285042418033669	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	STC2; CREB3L1; FGF21; ERN2;	GO:0030968~endoplasmic reticulum unfolded protein response	4	50	8	0.0287995105356824	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	NR2F2; NR2F1; EYA4; SIX2;	GO:0048856~anatomical structure development	4	50	8	0.0287995105356824	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
up	AZU1; CCR6; CCR5; CXCR5; CXCR3; CXCR1; CCR2; CCR8;	GO:0060326~cell chemotaxis	8	74	10.8108108108108	0.0293866449915682	0.438729433445946	1	1	0.9999999954262	0.9999999954262	1
down	GNA14; COL1A1; COL3A1; COL1A2; SAA1; ADRA2C;	GO:0030168~platelet activation	6	102	5.88235294117647	0.029462650900402	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	FZD7; WNT2; HOXC8; FZD8; FUT9; EN1; LHX8;	GO:0030182~neuron differentiation	7	131	5.34351145038168	0.0301269702387664	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	MIF; ISL1; NFATC4; TWIST1;	GO:0032760~positive regulation of tumor necrosis factor production	4	51	7.84313725490196	0.0305464859989488	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	FGF10; NGF; IGF1;	GO:0046579~positive regulation of Ras protein signal transduction	3	29	10.3448275862069	0.0309628907835549	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	NKX6-1; GPR17; TRPC4;	GO:0048709~oligodendrocyte differentiation	3	29	10.3448275862069	0.0309628907835549	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	AQP1; MT1A; MT1M;	GO:0071280~cellular response to copper ion	3	29	10.3448275862069	0.0309628907835549	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	IL1RAPL2; LRRC4B; GPC6;	GO:1905606~regulation of presynapse assembly	3	29	10.3448275862069	0.0309628907835549	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
up	CD300LD; CD300LF; CTLA4; IRF8; IRF4;	GO:0002376~immune system process	5	35	14.2857142857143	0.0313152465048357	0.452560203354628	1	1	0.9999999954262	0.9999999954262	1
up	LTF; SEMG1; DEFA4; DEFA3; S100A12;	GO:0031640~killing of cells of other organism	5	35	14.2857142857143	0.0313152465048357	0.452560203354628	1	1	0.9999999954262	0.9999999954262	1
down	TNFRSF11B; GIP; DRD2; LOX; AQP1; ADRA1A; NNMT; GABRG3; WFDC1;	GO:0042493~response to drug	9	193	4.66321243523316	0.0315882591168712	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
up	CRYBA1; IL10; CLEC4A;	GO:0001818~negative regulation of cytokine production	3	13	23.0769230769231	0.0318668172719897	0.452560203354628	1	1	0.9999999954262	0.9999999954262	1
up	APOA2; S100A8; HP;	GO:0002526~acute inflammatory response	3	13	23.0769230769231	0.0318668172719897	0.452560203354628	1	1	0.9999999954262	0.9999999954262	1
up	JCHAIN; IGKV3-20; IGHA2;	GO:0003094~glomerular filtration	3	13	23.0769230769231	0.0318668172719897	0.452560203354628	1	1	0.9999999954262	0.9999999954262	1
up	CD19; FCGR2B; TLR8;	GO:0016064~immunoglobulin mediated immune response	3	13	23.0769230769231	0.0318668172719897	0.452560203354628	1	1	0.9999999954262	0.9999999954262	1
down	NR2F1; NR2F2; NR0B1; ESRRG;	GO:0043401~steroid hormone mediated signaling pathway	4	52	7.69230769230769	0.0323546028462069	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	CAPN9; ALPI; CYP39A1;	GO:0007586~digestion	3	30	10	0.033529158518975	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	NGF; IGF1; ISL1;	GO:0043388~positive regulation of DNA binding	3	30	10	0.033529158518975	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	ADRA2C; ADRA1A; ADRA1B;	GO:0045907~positive regulation of vasoconstriction	3	30	10	0.033529158518975	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	KCNK2; GIP; DRD2;	GO:0048678~response to axon injury	3	30	10	0.033529158518975	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	IL11; ANGPT1; FGF21;	GO:2000352~negative regulation of endothelial cell apoptotic process	3	30	10	0.033529158518975	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
up	OR2A1; OR2T8; GPR25; P2RY10; FCN1; GPR171; FFAR3; MCF2L; RAMP3; UTS2; POMC; PF4; ADRA2A; HRH2; CXCR1; FPR3; AVPR2; CXCR5; SSTR3; CNR2; AVPR1A; CCR2; XCL1; CXCR3; GPR15; HTR6; CCR5; CCR6; CCR8; CCL23; OR2B6; NLRP6; TAS2R40; TAS2R41; TAS2R50; RGS1; PTGDR; ADGRE1; ACKR1; OR2B11; PIK3R6; OR2W3; GPR65; OR10G2; OR10AD1; OR52N4; OR52K2; OR52K1; GPR150; OR6N1; OR52P1P; RXFP4; RXFP2; PIK3R5; F2RL3; NPY6R; P2RY13; ADGRE3; P2RY12; NMUR1; PROK2; CYSLTR2; TAS2R13; XCL2; GPR55; OR4D1; OR13A1; GPR152;	GO:0007186~G protein-coupled receptor signaling pathway	68	1152	5.90277777777778	0.0348834734833779	0.473468352111889	1	1	0.9999999954262	0.9999999954262	1
down	AGT; COL1A1; AQP1; SCX; PIEZO2;	GO:0071260~cellular response to mechanical stimulus	5	79	6.32911392405063	0.0350146083174578	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	AGT; NTF4; ADRA1A;	GO:0007202~activation of phospholipase C activity	3	31	9.67741935483871	0.0362023542995111	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	GLI2; BMP5; TBX5;	GO:0007389~pattern specification process	3	31	9.67741935483871	0.0362023542995111	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
up	HBZ; EPB42; TAL1;	GO:0043249~erythrocyte maturation	3	14	21.4285714285714	0.0374462309772208	0.484873623168278	1	1	0.9999999954262	0.9999999954262	1
up	ADRA2A; LILRB2; LILRB1;	GO:0051926~negative regulation of calcium ion transport	3	14	21.4285714285714	0.0374462309772208	0.484873623168278	1	1	0.9999999954262	0.9999999954262	1
up	UPK3A; SLC12A3; SLC12A1;	GO:0055078~sodium ion homeostasis	3	14	21.4285714285714	0.0374462309772208	0.484873623168278	1	1	0.9999999954262	0.9999999954262	1
up	CD40LG; XCL1; TIGIT; TLR9;	GO:0032733~positive regulation of interleukin-10 production	4	25	16	0.0381963221224857	0.490976082172973	1	1	0.9999999954262	0.9999999954262	1
down	GFRA3; NR2F2; CXCL12; NKX6-1; CDK5R2; TWIST1;	GO:0001764~neuron migration	6	109	5.5045871559633	0.0382937664375894	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	MESP2; TBX2; FOXC2; MESP1; TMEM100; CNTN6;	GO:0007219~Notch signaling pathway	6	109	5.5045871559633	0.0382937664375894	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	SCX; MESP1; MESP2;	GO:0001707~mesoderm formation	3	32	9.375	0.0389816586608166	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	HOXD11; FOXG1; EN1;	GO:0009953~dorsal/ventral pattern formation	3	32	9.375	0.0389816586608166	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	NR2F1; NR2F2; NR0B1;	GO:0030522~intracellular receptor signaling pathway	3	32	9.375	0.0389816586608166	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	COMP; LTBP2; C1QTNF5; RAB3B;	GO:0009306~protein secretion	4	56	7.14285714285714	0.0402020107396643	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	FGF10; FGF7; SYDE1; NRK;	GO:0031532~actin cytoskeleton reorganization	4	56	7.14285714285714	0.0402020107396643	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	IGF1; NYAP1; PREX2;	GO:0014065~phosphatidylinositol 3-kinase signaling	3	33	9.09090909090909	0.0418661315589979	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	ADAMTS12; TNMD; TMEM100;	GO:0071773~cellular response to BMP stimulus	3	33	9.09090909090909	0.0418661315589979	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
down	COL11A1; ATP6V1B1; ITGA8; FOXG1;	GO:0042472~inner ear morphogenesis	4	57	7.01754385964912	0.0423180554006329	0.168338462244695	1	1	0.999492318039222	0.999492318039222	1
up	NLRP6; IRF4; TLR9;	GO:0034122~negative regulation of toll-like receptor signaling pathway	3	15	20	0.0434886002757838	0.513883686639576	1	1	0.9999999954262	0.9999999954262	1
up	IFNG; IL2RA; CTLA4;	GO:0045589~regulation of regulatory T cell differentiation	3	15	20	0.0434886002757838	0.513883686639576	1	1	0.9999999954262	0.9999999954262	1
up	IFNG; FCER2; TLR9;	GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process	3	15	20	0.0434886002757838	0.513883686639576	1	1	0.9999999954262	0.9999999954262	1
down	BMP5; LUM; DLX2; CHRDL2;	GO:0051216~cartilage development	4	58	6.89655172413793	0.0444957957082293	0.174978784952813	1	1	0.999492318039222	0.999492318039222	1
up	GPR65; P2RY10; F2RL3; GPR174; GPR55;	GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	5	39	12.8205128205128	0.0447610792490385	0.513883686639576	1	1	0.9999999954262	0.9999999954262	1
down	SLIT3; ZFPM2; ROBO2;	GO:0060412~ventricular septum morphogenesis	3	34	8.82352941176471	0.0448547202038347	0.174978784952813	1	1	0.999492318039222	0.999492318039222	1
up	MMP8; SCIMP; LILRB2; TLR9; TLR8; TLR7;	GO:0032755~positive regulation of interleukin-6 production	6	53	11.3207547169811	0.046670026641872	0.513883686639576	1	1	0.9999999954262	0.9999999954262	1
down	UCHL1; CERS1; HTR1B; FGF21;	GO:0035690~cellular response to drug	4	59	6.77966101694915	0.0467351614598865	0.179512063076632	1	1	0.999492318039222	0.999492318039222	1
down	AGR2; FGF2; DRD2; ZFPM2;	GO:0060548~negative regulation of cell death	4	59	6.77966101694915	0.0467351614598865	0.179512063076632	1	1	0.999492318039222	0.999492318039222	1
up	IFNG; IL10; CLEC6A; CLEC9A;	GO:0050715~positive regulation of cytokine secretion	4	27	14.8148148148148	0.0472185339126155	0.513883686639576	1	1	0.9999999954262	0.9999999954262	1
down	FGF10; GDNF; EYA4;	GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	3	35	8.57142857142857	0.0479462665634074	0.183880211827921	1	1	0.999492318039222	0.999492318039222	1
up	JCHAIN; IGKC; IGHG3; IGHA2; LTF;	GO:0001895~retina homeostasis	5	40	12.5	0.0485845563999103	0.513883686639576	1	1	0.9999999954262	0.9999999954262	1
down	IGF1; DDR2; TMEM119; CTHRC1;	GO:0045669~positive regulation of osteoblast differentiation	4	60	6.66666666666667	0.0490360386651467	0.18777030805777	1	1	0.999492318039222	0.999492318039222	1
up	CCR2; XCL1; XCL2;	GO:0010820~positive regulation of T cell chemotaxis	3	16	18.75	0.0499842187283259	0.513883686639576	1	1	0.9999999954262	0.9999999954262	1
up	TLR9; TLR8; TLR7;	GO:0034162~toll-like receptor 9 signaling pathway	3	16	18.75	0.0499842187283259	0.513883686639576	1	1	0.9999999954262	0.9999999954262	1
up	UPK3A; SLC12A3; SLC12A1;	GO:0055075~potassium ion homeostasis	3	16	18.75	0.0499842187283259	0.513883686639576	1	1	0.9999999954262	0.9999999954262	1
